Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TCRT | CSBR | PRPH | ||
| Company | Alaunos Therapeutics Inc | Champions Oncolog | Prophase Labs Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.19 | 5.09 | 3.13 | ||
| High | 4.31 | 5.23 | 3.27 | ||
| Low | 4.00 | 4.86 | 3.06 | ||
| Last | 4.08 | 5.05 | 3.11 | ||
| Change | -0.14 | +0.01 | -0.01 | ||
| % Change | -3.32% | +0.10% | -0.32% | ||
| Volume | 35,500 | 9,400 | 30,700 | ||
| 20-Day Average Volume | 18,028 | 3,890 | 32,335 | ||
| Previous Close | 4.22 | 5.05 | 3.12 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 6.18 | 5.00 | 3.62 | ||
| 20-Day Raw Stochastic | 2.15% | 42.50% | 3.49% | ||
| 20-Day Relative Strength | 27.68% | 52.22% | 28.36% | ||
| Weighted Alpha | -89.26 | -19.45 | -57.30 | ||
| Today's Opinion | 100% Sell | 40% Sell | 88% Sell | ||
| Previous Opinion | 100% Sell | 40% Sell | 88% Sell | ||
| Last Month's Opinion | 88% Sell | 56% Sell | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.82% since 07/15/24 | +0.80% since 07/15/24 | -3.42% since 07/15/24 | ||
| Low | 4.00 on 07/22/24 | 4.86 on 07/22/24 | 3.06 on 07/22/24 | ||
| High | 6.40 on 07/16/24 | 5.44 on 07/19/24 | 3.43 on 07/17/24 | ||
| 1-Month | |||||
| %Chg | -41.72% since 06/21/24 | +1.00% since 06/21/24 | -29.16% since 06/21/24 | ||
| Low | 4.00 on 07/22/24 | 4.85 on 07/05/24 | 3.06 on 07/22/24 | ||
| High | 7.72 on 06/24/24 | 5.44 on 07/19/24 | 4.49 on 06/24/24 | ||
| 3-Month | |||||
| %Chg | -62.57% since 04/22/24 | -0.20% since 04/19/24 | -36.53% since 04/22/24 | ||
| Low | 4.00 on 07/22/24 | 4.50 on 05/30/24 | 3.06 on 07/22/24 | ||
| High | 14.20 on 05/09/24 | 5.44 on 07/19/24 | 5.62 on 05/06/24 | ||
| 6-Month | |||||
| %Chg | -78.57% since 01/22/24 | -20.85% since 01/22/24 | -39.14% since 01/22/24 | ||
| Low | 4.00 on 07/22/24 | 4.50 on 05/30/24 | 3.06 on 07/22/24 | ||
| High | 32.85 on 01/24/24 | 6.46 on 01/23/24 | 7.48 on 04/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 67,575 | 68,582 | 59,526 | ||
| Shares Outstanding, K | 16,013 | 13,594 | 19,079 | ||
| Annual Sales | 10,000 | 53,870,000 | 44,380,000 | ||
| Annual Net Income | -35,140,000 | -5,340,000 | -16,780,000 | ||
| Last Quarter Sales | 0 | 12,020,000 | 3,630,000 | ||
| Last Quarter Net Income | -1,680,000 | -2,530,000 | -6,270,000 | ||
| 60-Month Beta | -0.49 | 0.49 | -0.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 05/15/24 | -0.19 on 03/12/24 | -0.07 on 05/09/24 | ||
| Latest Earnings Date | 08/12/24 | 09/11/24 | 08/08/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||